| RS886037756 |
PAX2
|
Health Risk |
Pathogenic |
— |
| RS886037757 |
PAX2
|
Health Risk |
Pathogenic |
— |
| RS886037758 |
KIF26B
|
Health Risk |
Pathogenic |
— |
| RS886037759 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Inborn genetic diseases |
| RS886037762 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS886037763 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS886037764 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS886037765 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS886037766 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS886037767 |
GRHL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated cleft palate, Van der Woude syndrome 2 |
| RS886037768 |
GRHL3
|
Health Risk |
Pathogenic |
Isolated cleft palate, Isolated cleft palate |
| RS886037769 |
GRHL3
|
Health Risk |
Pathogenic |
Isolated cleft palate, Isolated cleft palate |
| RS886037770 |
GRHL3
|
Health Risk |
Pathogenic |
Isolated cleft palate, Isolated cleft palate |
| RS886037771 |
RMND1
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS886037772 |
RMND1
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS886037773 |
RMND1
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS886037774 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS886037775 |
LPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipoproteinemia, type I |
| RS886037776 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Autism spectrum disorder |
| RS886037777 |
LIG4
|
Health Risk |
Likely pathogenic |
DNA ligase IV deficiency, DNA ligase IV deficiency |
| RS886037778 |
MYL4
|
Health Risk |
Pathogenic |
Familial atrial fibrillation, Atrial fibrillation |
| RS886037779 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Heimler syndrome 2, Peroxisome biogenesis disorder 4A (Zellweger) |
| RS886037780 |
PEX6
|
Health Risk |
Pathogenic |
Heimler syndrome 2, Heimler syndrome 2 |
| RS886037781 |
PEX6
|
Health Risk |
Pathogenic |
Heimler syndrome 2, Heimler syndrome 2 |
| RS886037782 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Heimler syndrome 2, Heimler syndrome 2 |
| RS886037783 |
PEX1
|
Health Risk |
Pathogenic |
Heimler syndrome 1, Zellweger spectrum disorders |
| RS886037784 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037785 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037786 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS886037787 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037788 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS886037789 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS886037790 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037793 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast neoplasm |
| RS886037797 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS886037798 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037799 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS886037800 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037801 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Hereditary breast ovarian cancer syndrome |
| RS886037802 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary breast ovarian cancer syndrome |
| RS886037803 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037804 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS886037805 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS886037806 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary breast ovarian cancer syndrome |
| RS886037807 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS886037808 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS886037809 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS886037810 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS886037811 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS886037812 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS886037814 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary breast ovarian cancer syndrome |
| RS886037815 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary breast ovarian cancer syndrome |
| RS886037816 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS886037817 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS886037818 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS886037819 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS886037822 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS886037823 |
BGN
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Meester-Loeys syndrome |
| RS886037825 |
BGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Meester-Loeys syndrome |
| RS886037827 |
NSMCE3
|
Health Risk |
Pathogenic |
Lung damage, immunodeficiency and chromosome breakage syndrome |
| RS886037828 |
OPA3
|
Health Risk |
Likely pathogenic |
Optic atrophy 3, Optic atrophy 3 |
| RS886037829 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS886037830 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS886037831 |
HOXD13
|
Health Risk |
Pathogenic |
Synpolydactyly type 1, Synpolydactyly type 1 |
| RS886037832 |
TWNK
|
Health Risk |
Pathogenic |
Infantile onset spinocerebellar ataxia, Infantile onset spinocerebellar ataxia |
| RS886037834 |
PKD1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Situs inversus, Heterotaxy |
| RS886037835 |
TMEM126B
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 29 |
| RS886037836 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS886037837 |
FGFR2
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Pfeiffer syndrome |
| RS886037841 |
TNIK
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 54 |
| RS886037842 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome, Congenital myasthenic syndrome 11 |
| RS886037843 |
POLG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute liver failure, Mitochondrial DNA depletion syndrome 16A |
| RS886037844 |
HADHB
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency 2, Mitochondrial trifunctional protein deficiency 2 |
| RS886037846 |
DGUOK
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) |
| RS886037847 |
SIN3A
|
Health Risk |
Pathogenic/Likely pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS886037848 |
GANAB
|
Health Risk |
Pathogenic |
POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE, POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE |
| RS886037849 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mutilating keratoderma, Mutilating keratoderma |
| RS886037850 |
SLC5A2
|
Health Risk |
Pathogenic |
Familial renal glucosuria, Familial renal glucosuria |
| RS886037851 |
SLC25A12
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 39 |
| RS886037853 |
TENM3
|
Health Risk |
Pathogenic |
MICROPHTHALMIA, SYNDROMIC 15 |
| RS886037854 |
MOCOS
|
Health Risk |
Pathogenic |
Xanthinuria type II, Xanthinuria type II |
| RS886037855 |
MOCOS
|
Health Risk |
Pathogenic |
Xanthinuria type II, Xanthinuria type II |
| RS886037856 |
BHLHA9
|
Health Risk |
Likely pathogenic |
Camptosynpolydactyly, complex |
| RS886037857 |
TMEM126B
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 29 |
| RS886037858 |
NUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, type IAA |
| RS886037859 |
STK11
|
Health Risk |
Pathogenic/Likely pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS886037860 |
DYNC2LI1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 15 with polydactyly, Short-rib thoracic dysplasia 15 with polydactyly |
| RS886037861 |
DNM1L
|
Health Risk |
Pathogenic |
Encephalopathy, lethal |
| RS886037862 |
MFF
|
Health Risk |
Pathogenic |
Encephalopathy due to defective mitochondrial and peroxisomal fission 2, Encephalopathy due to defective mitochondrial and peroxisomal fission 2 |
| RS886037863 |
INS
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 10, Maturity-onset diabetes of the young type 10 |
| RS886037864 |
BCL11A
|
Health Risk |
Pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS886037865 |
BCL11A
|
Health Risk |
Pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS886037866 |
BCL11A
|
Health Risk |
Pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS886037867 |
BCL11A
|
Health Risk |
Pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS886037868 |
BCL11A
|
Health Risk |
Likely pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS886037869 |
IFT52
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 16 with or without polydactyly, Short rib-polydactyly syndrome |
| RS886037870 |
IFT52
|
Health Risk |
Pathogenic/Likely pathogenic |
Short-rib thoracic dysplasia 16 with or without polydactyly, Short rib-polydactyly syndrome |
| RS886037871 |
AIP
|
Health Risk |
Likely pathogenic |
Familial isolated pituitary adenoma, Familial isolated pituitary adenoma |
| RS886037873 |
IARS1
|
Health Risk |
Pathogenic |
Growth retardation, intellectual developmental disorder |
| RS886037874 |
IARS1
|
Health Risk |
Pathogenic |
Growth retardation, intellectual developmental disorder |